Grifols SA (GRFS)
7.91
-0.16
(-1.98%)
USD |
NASDAQ |
Apr 29, 16:00
8.00
+0.09
(+1.14%)
Pre-Market: 09:13
Grifols Total Liabilities (Quarterly) : 14.26B for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Cellectis SA | 255.58M |
| Trinity Biotech Plc | 158.43M |
| Akari Therapeutics Plc | 19.67M |
| NuCana Plc | 7.407M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 23.20B |
| Shareholders Equity (Quarterly) | 6.191B |
| Debt to Equity Ratio | 1.659 |
| Current Ratio | 2.513 |
| Net Debt Paydown Yield | 2.29% |